Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03457480 · ClinicalTrials.gov registry record · NA

Text Messages in Preventing Tobacco Use in Young Adults

A NA study of Healthy Subject, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
781
Enrollment target
1
Study location

NCT03457480 is a NA study of Healthy Subject that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 781 participants, above the 199-participant average among 16 other Healthy Subject trials with a reported enrollment target (292% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03457480, a NA study of Healthy Subject, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
781 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well text messages work in preventing tobacco use in young adults. Text messaging may help to teach young adults about the risks of tobacco products.

Conditions Studied

Interventions

  • OTHER Survey Administration
  • BEHAVIORAL Focus Group
  • OTHER Informational Intervention
  • OTHER Computer-Assisted Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 781 participants
Start Date 2013-09-20
Est. Completion 2021-01-29
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03457480

The ClinicalTrials.gov registry entry for NCT03457480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 781 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 199-participant average among 16 other Healthy Subject trials with a reported enrollment target (292% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT03457480 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03457480 about?

NCT03457480 is a clinical study titled "Text Messages in Preventing Tobacco Use in Young Adults". This trial studies how well text messages work in preventing tobacco use in young adults. Text messaging may help to teach young adults about the risks of tobacco products.

What is the current status of trial NCT03457480?

This trial is currently completed. It is a NA study. The enrollment target is 781 participants. The study started on 2013-09-20. Estimated completion is 2021-01-29.

What conditions does trial NCT03457480 study?

This clinical trial studies the following conditions: Healthy Subject.

What interventions are being tested in trial NCT03457480?

The interventions under investigation include: Survey Administration (OTHER), Focus Group (BEHAVIORAL), Informational Intervention (OTHER), Computer-Assisted Intervention (OTHER).

Who is sponsoring clinical trial NCT03457480?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03457480 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.